# Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes

Study · id `cardio:ct-nct04583462` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04583462](<https://clinicaltrials.gov/study/NCT04583462>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04583462

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 230 participants.

## Technical summary

Registry record NCT04583462. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-02 (actual); primary completion 2027-09-29 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 230 participants (planned count; ClinicalTrials.gov record NCT04583462, source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)
- Started: 2021-06-02 (actual) (ClinicalTrials.gov record NCT04583462, source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)
- Primary completion: 2027-09-29 (anticipated) (ClinicalTrials.gov record NCT04583462, source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)
- Completion: 2027-10-29 (anticipated) (ClinicalTrials.gov record NCT04583462, source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT04583462, source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04583462-2025-11-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
- Acronym: IMPACT-1D
- Condition: Type 1 Diabetes
- Condition: Peripheral Arterial Calcification
- Intervention (Drug): Metformin
- Intervention (Drug): Placebo
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Type 1 diabetes (`core:type-1-diabetes`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 685dd3bbfc9a6de1e0b7f6b5be054e69b177ebf7659a5d148527938606c77cbe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
